AI주식인사이트AI Stock Insight
C

오상헬스케어

036220KOSDAQ의료용 기기 제조업

54.1 / 100

Reference Date: 2026-04-13

Financial Score18.0 / 40
News Sentiment19.1 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Declined 14.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Osang Healthcare is a company specializing in in vitro diagnostics (IVD), developing and selling biochemical, immunoassay, and molecular diagnostic products, including blood glucose meters, HbA1c devices, and cholesterol meters. It operates subsidiaries in the US and Brazil to expand its global market and is also pursuing new ventures in bio-healthcare.

Number of Employees

336people

Average Salary

57.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
37.17Industry Average 26.523.0Point

Higher than industry avg (caution)

PBR
0.43Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE
1.10Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
10.95Industry Average 10.954.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.8% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼3.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 14.8% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 8,400Won52-week high 23,05052-week low 8,220
1-month return1.0Point

1m -14.46% (falling)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

11 totalPositive 0Neutral 11Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-06
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-06
  • Neutral주식매수선택권부여에관한신고2026-03-26
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
  • Neutral정기주주총회결과2026-03-26